Relationship between sex, body size, and cardiac resynchronization therapy benefit: A patient-level meta-analysis of

Daniel J Friedman1, Antonio Olivas-Martinez2, Frederik Dalgaard3

  • 1Division of Cardiology, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.

Heart Rhythm
|February 15, 2024
PubMed

Insights

Women may experience greater benefits from cardiac resynchronization therapy (CRT) than men, especially with shorter QRS durations. Body size partially explains these differences, suggesting improved patient selection for CRT.

Area of Science:

  • Cardiology
  • Medical Devices
  • Biomedical Engineering

Background:

  • Cardiac resynchronization therapy (CRT) is a treatment for heart failure.
  • Previous studies suggest women may benefit more from CRT than men.
  • Sex-based differences in CRT effectiveness require further investigation.

Purpose of the Study:

  • To determine if height, body surface area (BSA), or left ventricular end-diastolic dimension (LVEDD) better account for sex-based differences in CRT effects.
  • To analyze patient-level data from multiple CRT trials.

Main Methods:

  • Bayesian hierarchical Weibull regression models were used to analyze data from seven major CRT trials.
  • QRS duration and CRT effects were examined overall and stratified by sex.
  • QRS duration was indexed by height, BSA, or LVEDD to assess its impact on CRT outcomes.

Main Results:

  • Women (n=1439) were shorter and had smaller BSAs than men (n=5628).
  • The reduction in heart failure hospitalization (HFH) or death was significantly greater for women (HR, 0.54) than for men (HR, 0.77).
  • CRT effects were observed at shorter QRS durations in women (126 ms) compared to men (145 ms), particularly in nonischemic cardiomyopathy.

Conclusions:

  • Body size partially explains sex-specific QRS duration thresholds for CRT benefit.
  • Indexing QRS duration for body size may enhance patient selection for CRT, especially for those with borderline QRS durations.
  • While body size influences thresholds, it does not appear to affect the magnitude of CRT benefit.
Abstract